Neuroleptic malignant syndrome

Retamal, P.

Revista Medica de Chile 118(6): 679-685

1990


ISSN/ISBN: 0034-9887
PMID: 1685596
Document Number: 354890
This is a review article on neuroleptic malignant syndrome. Clinical manifestations and differential diagnosis are discussed. Treatment is based on suppression of the drug and administration of bromocriptine and dantrolene. After recovery, neuroleptics should be withheld or a drug with low dopaminergic blocking effect would be selected.

Document emailed within 1 workday
Secure & encrypted payments